• Sectors
    • Tech
    • Healthcare
    • Consumer
    • Energy
    • Mining & Metals
    • Business Services
    • Financials
    • Telecom
    • Industrials
    • Transportation
    • Aerospace & Defense
    • Real Estate
    • Utilities
  • Spotlight Stocks
  • CEO Interview
    • Investor Presentations
  • Newsmakers
  • Investing Strategy
    • Investment Research – Sponsored Reports
    • Analyst Reports
    • Insider Trading
    • Smart Money
  • Funds & ETF’s
  • Markets
    • Commodities
    • Currencies
    • Economy
    • Lending & Interest Rates
  • Business News
    • Trading Ideas
  • Executive Resources
    • Leadership & Strategy
    • Capital
    • Law
  • Investor Education
    • Long Term Investing
    • Personal Finance
    • Stock Trading
    • Options Trading
    • Forex Trading
    • Futures Trading
  • EVENTS
    • Next Super Stock LIVE! – The Online Investor Conference
    • INVESTORS DISCOVERY DAY Livestream
Newswire
  • [ September 15, 2025 ] “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP) CEO Interview
  • [ September 15, 2025 ] Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business CEO Interview
  • [ September 15, 2025 ] NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market CEO Interview
  • [ September 15, 2025 ] Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL! Aerospace & Defense
  • [ September 15, 2025 ] Next Super Stock (NASDAQ: ADN) Hydrogen Fuel Cell Tech: Future of ENERGY $100 Billion Opportunity! Aerospace & Defense
  • [ September 15, 2025 ] (NASDAQ: HOTH) Advances Biotech Portfolio w Multiple Catalysts for 10X Upside Potential CEO Interview
  • [ September 10, 2025 ] Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus Newsmakers
  • [ September 10, 2025 ] Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities Newsmakers
  • [ September 10, 2025 ] Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early Newsmakers
  • [ September 4, 2025 ] Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ]. Newsmakers
Home2021January

Month: January 2021

No Picture
Trading Ideas

China Is Fueling South America’s Oil Boom

January 1, 2021 admin Comments Off on China Is Fueling South America’s Oil Boom

…read more […]

No Picture
Trading Ideas

10 Worst Performing S&P 500 Stocks Of 2020

January 1, 2021 admin Comments Off on 10 Worst Performing S&P 500 Stocks Of 2020

…read more […]

No Picture
Trading Ideas

How a weekly Twitter poll crushed the S&P 500 in 2020

January 1, 2021 admin Comments Off on How a weekly Twitter poll crushed the S&P 500 in 2020

…read more […]

No Picture
Trading Ideas

Top 4 Large-Cap ETFs for 2020

January 1, 2021 admin Comments Off on Top 4 Large-Cap ETFs for 2020

…read more […]

No Picture
Trading Ideas

Dow Jones Futures: Stock Market Rally Lessons For 2021; Tesla, Nio Await Key News; 25 Stocks In Buy Range Now

January 1, 2021 admin Comments Off on Dow Jones Futures: Stock Market Rally Lessons For 2021; Tesla, Nio Await Key News; 25 Stocks In Buy Range Now

…read more […]

No Picture
Trading Ideas

Here’s why the Georgia runoff elections for the U.S. Senate could turn into a ‘big deal’ for markets

January 1, 2021 admin Comments Off on Here’s why the Georgia runoff elections for the U.S. Senate could turn into a ‘big deal’ for markets

…read more […]

No Picture
Trading Ideas

The second U.S. stimulus payments could arrive soon. Here’s what to consider before you spend it.

January 1, 2021 admin Comments Off on The second U.S. stimulus payments could arrive soon. Here’s what to consider before you spend it.

…read more […]

No Picture
Trading Ideas

Alibaba and Other Chinese Tech Stocks Can Weather Scrutiny From Regulators, VanEck’s Semple Says

January 1, 2021 admin Comments Off on Alibaba and Other Chinese Tech Stocks Can Weather Scrutiny From Regulators, VanEck’s Semple Says

…read more […]

No Picture
Trading Ideas

Merck Is One of Barron’s Top Stock Picks for the New Year. Here’s Why.

January 1, 2021 admin Comments Off on Merck Is One of Barron’s Top Stock Picks for the New Year. Here’s Why.

…read more […]

No Picture
Trading Ideas

How to Set Up a Backdoor Roth IRA

January 1, 2021 admin Comments Off on How to Set Up a Backdoor Roth IRA

…read more […]

No Picture
Trading Ideas

NYSE to delist 3 biggest Chinese telecoms to comply with Trump executive order

January 1, 2021 admin Comments Off on NYSE to delist 3 biggest Chinese telecoms to comply with Trump executive order

…read more […]

No Picture
Trading Ideas

Time to Go Bargain Hunting on Arcturus Stock? Analyst Weighs In

January 1, 2021 admin Comments Off on Time to Go Bargain Hunting on Arcturus Stock? Analyst Weighs In

…read more […]

No Picture
Trading Ideas

Why BlackRock Stock Will Continue to Rock

January 1, 2021 admin Comments Off on Why BlackRock Stock Will Continue to Rock

…read more […]

No Picture
Trading Ideas

Alibaba Is Strong Enough to Face the Regulators, Says Analyst

January 1, 2021 admin Comments Off on Alibaba Is Strong Enough to Face the Regulators, Says Analyst

…read more […]

No Picture
Trading Ideas

The Most Outrageous 2020 Oil Predictions

January 1, 2021 admin Comments Off on The Most Outrageous 2020 Oil Predictions

…read more […]

Posts navigation

« 1 … 100 101 102 »

Featured Stocks

newsmakers

  • Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus
    September 10, 2025 Comments Off on Advent Technologies (NASDAQ: ADN) Announces Major Milestone in its Strategic Collaboration with Airbus
  • Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
    September 10, 2025 Comments Off on Hoth Therapeutics (NASDAQ: HOTH) Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
  • Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early
    September 10, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Fourth Consecutive Monthly Sales Record in July 2025; Gross Margin Reaches 31% Target One Quarter Early
  • Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].
    September 4, 2025 Comments Off on Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].
  • Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
    September 4, 2025 Comments Off on Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
  • No Picture
    Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030
    August 28, 2025 Comments Off on Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

NEXT SUPER STOCK

  • “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
    September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
  • Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
    September 15, 2025 Comments Off on Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
  • NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
    September 15, 2025 Comments Off on NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
  • Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!
    September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

CEO Interview

  • “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
    September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)
  • Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
    September 15, 2025 Comments Off on Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business
  • NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
    September 15, 2025 Comments Off on NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market
  • Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!
    September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!
Next Super Stock
CEO Interview

“Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)

September 15, 2025 Comments Off on “Blue Collar TESLA” Can Increase 10X-100X ! NEXT SUPER STOCK Worksport (NASDAQ: WKSP)

NEXT SUPER STOCK Worksport (NASDAQ: WKSP) can increase +10X from $3.50 to $50.00 over the next 12 months. Here’s how: revenue $20 mil run rate – growing at +100% over […]

CEO Interview

Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: WGRX) Stock with +10X Upside Potential – Scaling to BILLION Dollar Pharma Business

NEXT SUPER STOCK Wellgistics (NASDAQ: WGRX) Scaling to $250 Mil+ Revenue next 12 mos. is “Extremely DOABLE” says CEO DO. THE. MATH. This could be worth 4X multiple = $1 […]

CEO Interview

NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market

September 15, 2025 Comments Off on NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) Emerging Leader in $600 BILLION Pharma Market

NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) is an emerging leader in $600 BILLION Pharma distribution market in the US. $WGRX is a young company at INFLECTION POINT for EXPLOSIVE GROWTH […]

Aerospace & Defense

Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) The FUTURE of Power for ROBOTS, DRONES, Air Taxis eVTOL!

Next Super Stock Advent Technologies (NASDAQ: ADN) Hydrogen Fuel Cells could be the future of ENERGY for Aviation, Robots, Drones, Ships and more –  $100 BILLION Market Opportunity. $ADN is […]

Aerospace & Defense

Next Super Stock (NASDAQ: ADN) Hydrogen Fuel Cell Tech: Future of ENERGY $100 Billion Opportunity!

September 15, 2025 Comments Off on Next Super Stock (NASDAQ: ADN) Hydrogen Fuel Cell Tech: Future of ENERGY $100 Billion Opportunity!

Next Super Stock Advent Technologies (NASDAQ: ADN) Hydrogen Fuel Cells could be the future of ENERGY for Aviation, Robots, Drones, Ships and more –  $100 BILLION Market Opportunity. $ADN is […]

  • Contact
  • About Us
  • Investor Relations Services
  • Terms of Use/Legal Notice
  • Login
  • Subscriptions
  • Submit Press Release
  • Privacy Policy

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.